Halil Önder Ersöz

1.8k total citations
56 papers, 1.2k citations indexed

About

Halil Önder Ersöz is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Halil Önder Ersöz has authored 56 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Halil Önder Ersöz's work include Pituitary Gland Disorders and Treatments (9 papers), Thyroid Disorders and Treatments (6 papers) and Thyroid Cancer Diagnosis and Treatment (6 papers). Halil Önder Ersöz is often cited by papers focused on Pituitary Gland Disorders and Treatments (9 papers), Thyroid Disorders and Treatments (6 papers) and Thyroid Cancer Diagnosis and Treatment (6 papers). Halil Önder Ersöz collaborates with scholars based in Türkiye, United States and Norway. Halil Önder Ersöz's co-authors include Cihangir Erem, Arif Hacıhasanoğlu, Kubilay Ükinç, Mustafa Koçak, Orhan Değer, Münir Telatar, Mustafa Yılmaz, Murat Topbaş, Caner Karahan and İrfan Nuhoğlu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Chemistry and International Journal of Obesity.

In The Last Decade

Halil Önder Ersöz

56 papers receiving 1.2k citations

Peers

Halil Önder Ersöz
Arif Hacıhasanoğlu Türkiye
Mustafa Koçak Türkiye
Helen E. Seaman United Kingdom
Barbara Głowińska‐Olszewska Poland
Jayaprakash Sahoo India
Sena Yeşil Türkiye
Ammon Handisurya Austria
Donatella Spotti Italy
Richard E. Scranton United States
Marja Pyörälä Finland
Arif Hacıhasanoğlu Türkiye
Halil Önder Ersöz
Citations per year, relative to Halil Önder Ersöz Halil Önder Ersöz (= 1×) peers Arif Hacıhasanoğlu

Countries citing papers authored by Halil Önder Ersöz

Since Specialization
Citations

This map shows the geographic impact of Halil Önder Ersöz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halil Önder Ersöz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halil Önder Ersöz more than expected).

Fields of papers citing papers by Halil Önder Ersöz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Halil Önder Ersöz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halil Önder Ersöz. The network helps show where Halil Önder Ersöz may publish in the future.

Co-authorship network of co-authors of Halil Önder Ersöz

This figure shows the co-authorship network connecting the top 25 collaborators of Halil Önder Ersöz. A scholar is included among the top collaborators of Halil Önder Ersöz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Halil Önder Ersöz. Halil Önder Ersöz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nuhoğlu, İrfan, et al.. (2023). Comparison of orlistat and orlistat plus metformin therapy between diabetic and nondiabetic groups. Revista da Associação Médica Brasileira. 69(7). e20230174–e20230174. 1 indexed citations
2.
Ersöz, Halil Önder, et al.. (2022). Efficacy of Multidisciplinary Approach in Thyroid Nodules: Analysis of Factors Used for Predicting Malignancy. SHILAP Revista de lepidopterología. 26(3). 125–130. 2 indexed citations
3.
Nuhoğlu, İrfan, et al.. (2021). Clinical research of insulin glargine U300 basal‐bolus therapy and insulin degludec/aspart co‐formulation in type 2 diabetes mellitus: A real world experience. International Journal of Clinical Practice. 75(9). e14377–e14377. 5 indexed citations
4.
Nuhoğlu, İrfan, et al.. (2021). Clinical research of insulin glargine U300 in type 1 diabetes mellitus patients with frequent hypoglycaemia: real-world experience. Archives of Medical Science - Atherosclerotic Diseases. 6(1). 102–108. 2 indexed citations
5.
Tök, Özlem, et al.. (2021). Effects of increased physical activity and/or weight loss diet on serum myokine and adipokine levels in overweight adults with impaired glucose metabolism. Journal of Diabetes and its Complications. 35(5). 107892–107892. 19 indexed citations
6.
Çebi, Alper Han, et al.. (2020). MicroRNA Expression Levels in Patients with Hashimoto Thyroiditis: A Single Centre Study. Endocrine Metabolic & Immune Disorders - Drug Targets. 21(6). 1066–1072. 3 indexed citations
7.
8.
Hocaoğlu, Çiçek, et al.. (2011). Tip 2 diyabetes mellituslu hastalarda yaşam kalitesi ve ruhsal belirtiler / Quality of life and psychiatric symptoms in the patients with type 2 diabetes mellitus. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 128–138. 6 indexed citations
9.
Ersöz, Halil Önder, Mustafa Yılmaz, Hülya Yılmaz, et al.. (2011). The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus. Acta Diabetologica. 48(4). 297–302. 84 indexed citations
10.
Ükinç, Kubilay, Halil Önder Ersöz, Cihangir Erem, et al.. (2009). A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin. Endocrine. 36(3). 425–432. 45 indexed citations
11.
Erem, Cihangir, Arif Hacıhasanoğlu, Orhan Değer, et al.. (2008). Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study. Endocrine. 33(1). 9–20. 64 indexed citations
12.
13.
Baykan, Merih, Cihangir Erem, T. Erdoğan, et al.. (2007). Assessment of left ventricular diastolic function and the Tei index by tissue Doppler imaging in patients with primary hyperparathyroidism. Clinical Endocrinology. 66(4). 483–488. 23 indexed citations
14.
Erem, Cihangir, Arif Hacıhasanoğlu, Akif Çinel, et al.. (2006). Carotid Body Tumors and Adrenal Pheochromocytomas in Siblings of a Turkish Family. Medical Principles and Practice. 15(5). 396–400. 3 indexed citations
15.
Erem, Cihangir, Arif Hacıhasanoğlu, Akif Çinel, et al.. (2004). Adrenal Black Adenoma Associated with Cushing's Syndrome. Endocrine. 25(3). 253–258. 5 indexed citations
16.
Ersöz, Halil Önder, Merih Baykan, Cihangir Erem, et al.. (2004). Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study. International Journal of Obesity. 28(3). 378–383. 12 indexed citations
17.
Erem, Cihangir, et al.. (2004). Radioiodine Treatment of Hyperthyroidism: Prognostic Factors Affecting Outcome. Endocrine. 25(1). 55–60. 32 indexed citations
18.
19.
Erem, Cihangir, Arif Hacıhasanoğlu, Ahmet Sarı, et al.. (2004). Intrathyroideal Papillary Thyroid Carcinoma Presenting with a Solitary Brain Metastasis. Endocrine. 25(2). 187–194. 5 indexed citations
20.
Erem, Cihangir, Arif Hacıhasanoğlu, Akif Çinel, et al.. (2004). Sphenoid sinus brown tumor, a mass lesion of occipital bone and hypercalcemia: An unusual presentation of primary hyperparathyroidism. Journal of Endocrinological Investigation. 27(4). 366–369. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arif Hacıhasanoğlu Breakdown of academic impact, for papers by Mustafa Koçak Breakdown of academic impact, for papers by Helen E. Seaman Breakdown of academic impact, for papers by Barbara Głowińska‐Olszewska Breakdown of academic impact, for papers by Jayaprakash Sahoo Breakdown of academic impact, for papers by Sena Yeşil Breakdown of academic impact, for papers by Ammon Handisurya Breakdown of academic impact, for papers by Donatella Spotti Breakdown of academic impact, for papers by Richard E. Scranton Breakdown of academic impact, for papers by Marja Pyörälä
Rankless by CCL
2026